B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy-Reference-Cited by-同舟云学术

B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy

Published:2008-06-15 Issue:11 Volume:85 Page:1648-1653
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Thaunat Olivier,Patey Natacha,Gautreau Chantal,Lechaton Sophie,Fremeaux-Bacchi Véronique,Dieu-Nosjean Marie-Caroline,Cassuto-Viguier Elisabeth,Legendre Christophe,Delahousse Michel,Lang Philippe,Michel Jean-Baptiste,Nicoletti Antonino

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference17 articles.

1. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.;Edwards;N Engl J Med,2004

2. B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab.;Looney;Arthritis Rheum,2004

3. Rituximab as treatment for refractory kidney transplant rejection.;Becker;Am J Transplant,2004

4. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.;Kratz;J Exp Med,1996

5. Lymphoid neogenesis in chronic inflammatory diseases.;Aloisi;Nat Rev Immunol,2006

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Immunological Biomarkers Associated With Rejection After Uterus Transplantation in Human;Transplantation;2024-07-18

2. Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial;American Journal of Transplantation;2024-07

3. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-01

4. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis;Frontiers in Immunology;2023-10-31

5. Transcriptome analysis of renal ischemia/reperfusion (I/R) injury in BAFF and BAFF-R deficient mice;PLOS ONE;2023-09-26